

Prescription Drug Prices
Aug 21, 2024
The Biden administration has made waves by negotiating lower prices for ten common prescription drugs, set to save Medicare an estimated $6 billion by 2026. The podcast dives into the implications of these negotiations for consumers and healthcare policy. It covers diverse perspectives on how these changes could impact pharmaceutical innovation and market dynamics. Additionally, it discusses civil liberties concerns related to government oversight in healthcare. The episode wraps up with a heartwarming story about inclusion and belonging.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
Insights into Medicare and Prescription Drug Price Negotiations
01:46 • 3min
Negotiating Drug Prices: The Biden Administration's Approach
04:52 • 7min
Analyzing the Medicare Drug Price Negotiation Impact
11:39 • 5min
Medicare, Drug Prices, and Civil Liberties
16:50 • 10min
Insights on Medicare Drug Pricing and Heartwarming Inclusion
26:48 • 3min